We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$13B
Cap. Flow %
-6.47%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,429
Increased
3,737
Reduced
3,810
Closed
1,251

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.97%
2 Financials 4.82%
3 Healthcare 4.18%
4 Industrials 3.64%
5 Consumer Discretionary 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHAK icon
7251
Shake Shack
SHAK
$3.02B
$340K ﹤0.01%
+5,749
New +$295K
ETRN
7252
CALL
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$340K ﹤0.01%
15,600
-200
-1% -$4K
MNTA
7253
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$340K ﹤0.01%
23,400
-4,300
-16% -$54.9K
AGI icon
7254
CALL
Alamos Gold
AGI
$14B
$339K ﹤0.01%
+66,800
New +$304K
EAF icon
7255
PUT
GrafTech
EAF
$199M
$339K ﹤0.01%
2,650
-2,590
-49% -$344K
PCRX icon
7256
PUT
Pacira BioSciences
PCRX
$917M
$339K ﹤0.01%
8,900
-20,300
-70% -$792K
RYN icon
7257
Rayonier
RYN
$6.49B
$339K ﹤0.01%
11,860
-196,948
-94% -$5.25M
SBH icon
7258
CALL
Sally Beauty Holdings
SBH
$1.54B
$339K ﹤0.01%
18,400
+4,400
+31% +$78.6K
SILC icon
7259
Silicom
SILC
$285M
$339K ﹤0.01%
8,848
+742
+9% +$26.9K
VG
7260
PUT
DELISTED
Vonage Holdings Corporation
VG
$339K ﹤0.01%
33,800
-1,700
-5% -$16.3K
APPS icon
7261
Digital Turbine
APPS
$1.51B
$338K ﹤0.01%
96,646
+81,123
+523% +$223K
DOC icon
7262
PUT
Healthpeak Properties
DOC
$14.3B
$338K ﹤0.01%
10,800
-4,300
-28% -$131K
ONIT
7263
Onity Group
ONIT
$328M
$338K ﹤0.01%
12,392
-32,511
-72% -$915K
TCO
7264
CALL
DELISTED
Taubman Centers Inc.
TCO
$338K ﹤0.01%
6,400
+2,000
+45% +$101K
CKH
7265
PUT
DELISTED
Seacor Holdings Inc.
CKH
$338K ﹤0.01%
+8,000
New +$341K
AZTA icon
7266
Azenta
AZTA
$1.46B
$337K ﹤0.01%
11,491
+3,605
+46% +$108K
FPXI icon
7267
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$301M
$337K ﹤0.01%
9,687
-20,049
-67% -$672K
SMB icon
7268
VanEck Short Muni ETF
SMB
$314M
$337K ﹤0.01%
+19,182
New +$334K
DERM
7269
PUT
DELISTED
Dermira, Inc.
DERM
$337K ﹤0.01%
24,900
+4,700
+23% +$39.2K
BPMC
7270
PUT
DELISTED
Blueprint Medicines
BPMC
$336K ﹤0.01%
4,200
-7,500
-64% -$554K
MTRX icon
7271
Matrix Service
MTRX
$335M
$336K ﹤0.01%
17,146
-54,117
-76% -$1.11M
RFFC icon
7272
ALPS Active Equity Opportunity ETF
RFFC
$30.9M
$336K ﹤0.01%
10,228
-46,264
-82% -$1.48M
REGI
7273
PUT
DELISTED
Renewable Energy Group, Inc.
REGI
$336K ﹤0.01%
15,300
-7,500
-33% -$193K
FOR icon
7274
Forestar Group
FOR
$1.5B
$335K ﹤0.01%
19,347
-27,216
-58% -$446K
LADR
7275
CALL
Ladder Capital
LADR
$1.27B
$335K ﹤0.01%
19,700
+8,700
+79% +$149K

Similar funds

Ken Griffin's Q1 2019 Portfolio in Review

As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $13B in Q1 2019, closing 1,251 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.

  • Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Ken Griffin opened 1,429 new positions and closed 1,251 in Q1 2019.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.